UCA1 and pancreatic adenocarcinoma: As shown in (Figure 1(d)), higher expression levels of AC099850.3 (HR = 1.842, 95%CI = 1.303 − 2.605), UCA1 (HR = 1.314, 95%CI = 1.168 − 1.479) and AP005233.2 (HR = 1.234, 95%CI = 1.078 − 1.412) were associated with poorer prognoses in PAAD patients.